Utilidad clínica del condroitín sulfato
Clinical utility of condroitin sulfate
Read
7884
Timeswas read the article
2970
Total PDF
4914
Total HTML
Article information
ISSN: 02133717Original language: Spanish
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 86 | 20 | 106 |
| 2025 5 | 92 | 27 | 119 |
| 2025 4 | 87 | 25 | 112 |
| 2025 3 | 78 | 29 | 107 |
| 2025 2 | 61 | 30 | 91 |
| 2025 1 | 47 | 28 | 75 |
| 2024 12 | 70 | 44 | 114 |
| 2024 11 | 55 | 37 | 92 |
| 2024 10 | 67 | 40 | 107 |
| 2024 9 | 67 | 18 | 85 |
| 2024 8 | 98 | 43 | 141 |
| 2024 7 | 78 | 36 | 114 |
| 2024 6 | 74 | 20 | 94 |
| 2024 5 | 55 | 39 | 94 |
| 2024 4 | 47 | 32 | 79 |
| 2024 3 | 39 | 26 | 65 |
| 2024 2 | 39 | 26 | 65 |
| 2024 1 | 36 | 18 | 54 |
| 2023 12 | 45 | 26 | 71 |
| 2023 11 | 52 | 49 | 101 |
| 2023 10 | 57 | 37 | 94 |
| 2023 9 | 63 | 43 | 106 |
| 2023 8 | 57 | 23 | 80 |
| 2023 7 | 69 | 30 | 99 |
| 2023 6 | 42 | 30 | 72 |
| 2023 5 | 68 | 15 | 83 |
| 2023 4 | 76 | 19 | 95 |
| 2023 3 | 55 | 32 | 87 |
| 2023 2 | 48 | 27 | 75 |
| 2023 1 | 48 | 23 | 71 |
| 2022 12 | 56 | 36 | 92 |
| 2022 11 | 44 | 31 | 75 |
| 2022 10 | 76 | 60 | 136 |
| 2022 9 | 57 | 42 | 99 |
| 2022 8 | 47 | 41 | 88 |
| 2022 7 | 40 | 35 | 75 |
| 2022 6 | 59 | 49 | 108 |
| 2022 5 | 59 | 31 | 90 |
| 2022 4 | 36 | 38 | 74 |
| 2022 3 | 32 | 37 | 69 |
| 2022 2 | 32 | 46 | 78 |
| 2022 1 | 22 | 30 | 52 |
| 2021 12 | 19 | 45 | 64 |
| 2021 11 | 29 | 47 | 76 |
| 2021 10 | 26 | 37 | 63 |
| 2021 9 | 18 | 34 | 52 |
| 2021 8 | 30 | 67 | 97 |
| 2021 7 | 21 | 20 | 41 |
| 2021 6 | 34 | 32 | 66 |
| 2021 5 | 36 | 38 | 74 |
| 2021 4 | 49 | 36 | 85 |
| 2021 3 | 3 | 6 | 9 |
| 2020 12 | 21 | 7 | 28 |
| 2020 11 | 14 | 17 | 31 |
| 2020 10 | 28 | 27 | 55 |
| 2020 9 | 13 | 22 | 35 |
| 2020 8 | 18 | 16 | 34 |
| 2020 7 | 23 | 24 | 47 |
| 2020 6 | 17 | 19 | 36 |
| 2020 5 | 22 | 18 | 40 |
| 2020 4 | 16 | 14 | 30 |
| 2020 3 | 24 | 13 | 37 |
| 2020 2 | 25 | 17 | 42 |
| 2020 1 | 19 | 13 | 32 |
| 2019 12 | 16 | 16 | 32 |
| 2019 11 | 14 | 10 | 24 |
| 2019 10 | 9 | 10 | 19 |
| 2019 9 | 18 | 23 | 41 |
| 2019 8 | 16 | 13 | 29 |
| 2019 7 | 13 | 14 | 27 |
| 2019 6 | 22 | 14 | 36 |
| 2019 5 | 15 | 11 | 26 |
| 2019 4 | 18 | 39 | 57 |
| 2019 3 | 17 | 21 | 38 |
| 2019 2 | 13 | 21 | 34 |
| 2019 1 | 19 | 27 | 46 |
| 2018 12 | 19 | 29 | 48 |
| 2018 11 | 16 | 27 | 43 |
| 2018 10 | 22 | 11 | 33 |
| 2018 9 | 12 | 13 | 25 |
| 2018 7 | 0 | 1 | 1 |
| 2018 6 | 1 | 0 | 1 |
| 2018 4 | 27 | 16 | 43 |
| 2018 3 | 12 | 5 | 17 |
| 2018 2 | 14 | 4 | 18 |
| 2018 1 | 35 | 7 | 42 |
| 2017 12 | 22 | 15 | 37 |
| 2017 11 | 18 | 9 | 27 |
| 2017 10 | 17 | 11 | 28 |
| 2017 9 | 14 | 13 | 27 |
| 2017 8 | 12 | 26 | 38 |
| 2017 7 | 18 | 18 | 36 |
| 2017 6 | 27 | 35 | 62 |
| 2017 5 | 42 | 35 | 77 |
| 2017 4 | 211 | 35 | 246 |
| 2017 3 | 20 | 37 | 57 |
| 2017 2 | 45 | 27 | 72 |
| 2017 1 | 30 | 20 | 50 |
| 2016 12 | 37 | 16 | 53 |
| 2016 11 | 43 | 8 | 51 |
| 2016 10 | 56 | 15 | 71 |
| 2016 9 | 44 | 11 | 55 |
| 2016 8 | 34 | 11 | 45 |
| 2016 7 | 38 | 15 | 53 |
| 2016 6 | 36 | 17 | 53 |
| 2016 5 | 51 | 20 | 71 |
| 2016 4 | 37 | 28 | 65 |
| 2016 3 | 38 | 21 | 59 |
| 2016 2 | 65 | 20 | 85 |
| 2016 1 | 43 | 18 | 61 |
| 2015 12 | 43 | 21 | 64 |
| 2015 11 | 48 | 14 | 62 |
| 2015 10 | 141 | 8 | 149 |
| 2015 9 | 38 | 13 | 51 |
| 2015 8 | 33 | 13 | 46 |
| 2015 7 | 36 | 11 | 47 |
| 2015 6 | 23 | 3 | 26 |
| 2015 5 | 21 | 10 | 31 |
| 2015 4 | 30 | 9 | 39 |
| 2015 3 | 15 | 5 | 20 |
| 2015 2 | 24 | 13 | 37 |
| 2015 1 | 24 | 11 | 35 |
| 2014 12 | 29 | 28 | 57 |
| 2014 11 | 38 | 15 | 53 |
| 2014 10 | 36 | 11 | 47 |
| 2014 9 | 17 | 11 | 28 |
| 2014 8 | 27 | 5 | 32 |
| 2014 7 | 24 | 19 | 43 |
Show all
